O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial
B. Monk, T. Toita, Xiaohua Wu, Juan Carlos Limón, Qi Zhou, R. Tarnawski, M. Mandai, R. Shapira-Frommer, U. Mahantshetty, Maria Del Pilar Estevez-Diz, Francisco Ramirez Godinez, S. Varga, Manuel Humberto Leiva Gálvez, Jung-Yun Lee, Y. Kreynina, Kathryn Howells, S. Wildsmith, H. Dry, A. Nunes, J. Mayadev
{"title":"O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial","authors":"B. Monk, T. Toita, Xiaohua Wu, Juan Carlos Limón, Qi Zhou, R. Tarnawski, M. Mandai, R. Shapira-Frommer, U. Mahantshetty, Maria Del Pilar Estevez-Diz, Francisco Ramirez Godinez, S. Varga, Manuel Humberto Leiva Gálvez, Jung-Yun Lee, Y. Kreynina, Kathryn Howells, S. Wildsmith, H. Dry, A. Nunes, J. Mayadev","doi":"10.1136/ijgc-2022-igcs.3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":348678,"journal":{"name":"Oral Abstracts (Regular and Late-Breaking Submission)","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Abstracts (Regular and Late-Breaking Submission)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-igcs.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
